Bayzed Health Group Inc. (incorporated in the Cayman Islands and listed on the Main Board of HKEX) filed its Monthly Return for the period ended 31 May 2026, confirming a stable share-capital structure and full compliance with Hong Kong’s public-float requirements.

Authorised Capital • The authorised share capital remained unchanged at 5.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to USD 50,000.

Issued Shares and Public Float • Issued shares stood at 1,318,466,823 (approximately 1.32 billion). • No treasury shares were held or cancelled, and no new shares were issued or repurchased during the month. • The company confirmed adherence to the minimum 25% public-float threshold stipulated by HKEX Main Board Rule 13.32B.

Equity Incentives and Other Instruments • The post-IPO share option scheme (adopted 8 August 2023, amended 9 June 2025) showed zero outstanding options and no new grants, exercises or cancellations in May 2026. • The issuer reported no warrants, convertible securities or other equity-linked instruments outstanding or exercised during the period.

Overall, Bayzed Health’s capital structure was unchanged in May 2026, reflecting steady equity levels and regulatory compliance without any financing or treasury-share activity.